{"id":92,"date":"2015-10-23T11:01:12","date_gmt":"2015-10-23T16:01:12","guid":{"rendered":"http:\/\/www.masstortlawyerblog.com\/?p=92"},"modified":"2018-09-12T16:08:57","modified_gmt":"2018-09-12T21:08:57","slug":"california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds","status":"publish","type":"post","link":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/","title":{"rendered":"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds"},"content":{"rendered":"

In\u00a0Saavedra v. Eli Lilly & Co.<\/em>, the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they overpaid for the product but that they were harmed because they received a product that had less value than what they expected to receive. The plaintiffs sought to certify four classes under consumer fraud protection statutes in four jurisdictions: \u00a0California, Massachusetts, New York, and Missouri. Initially, the trial court rejected<\/a> these classes, stating that the plaintiffs had asserted an “unusual” theory of recovery. More specifically, the plaintiffs omitted any allegations indicating how they suffered or experienced the withdrawal symptoms.<\/p>\n

Instead, the plaintiffs contended that they received a product that had less utility, which they defined as the benefit they believed\u00a0they would receive from using the\u00a0product. The trial court rejected this theory, noting that it focused only on the refund associated with users’ out-of-pocket costs. In reality, the prescription drug market’s price and value relationship is severed due to the nature of how prescription drugs are marketed and sold.<\/p>\n

Continue reading \u2192<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

In\u00a0Saavedra v. Eli Lilly & Co., the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they overpaid for the product but that they were harmed because they received a product that had less value than what they expected to receive. The plaintiffs sought to certify four classes under consumer […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-92","post","type-post","status-publish","format-standard","hentry","category-pharmaceuticals"],"yoast_head":"\nCalifornia Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds — Illinois Injury and Mass Tort Lawyer Blog — October 23, 2015<\/title>\n<meta name=\"description\" content=\"In\u00a0Saavedra v. Eli Lilly & Co., the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they — October 23, 2015\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds — Illinois Injury and Mass Tort Lawyer Blog — October 23, 2015\" \/>\n<meta name=\"twitter:description\" content=\"In\u00a0Saavedra v. Eli Lilly & Co., the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they — October 23, 2015\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Moll Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds — Illinois Injury and Mass Tort Lawyer Blog — October 23, 2015","description":"In\u00a0Saavedra v. Eli Lilly & Co., the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they — October 23, 2015","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/","twitter_card":"summary_large_image","twitter_title":"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds — Illinois Injury and Mass Tort Lawyer Blog — October 23, 2015","twitter_description":"In\u00a0Saavedra v. Eli Lilly & Co., the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they — October 23, 2015","twitter_misc":{"Written by":"Moll Law Group","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/#article","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/"},"author":{"name":"Moll Law Group","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"headline":"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds","datePublished":"2015-10-23T16:01:12+00:00","dateModified":"2018-09-12T21:08:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/"},"wordCount":586,"articleSection":["Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/","url":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/","name":"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds — Illinois Injury and Mass Tort Lawyer Blog — October 23, 2015","isPartOf":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#website"},"datePublished":"2015-10-23T16:01:12+00:00","dateModified":"2018-09-12T21:08:57+00:00","author":{"@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90"},"description":"In\u00a0Saavedra v. Eli Lilly & Co., the plaintiffs brought suit against the manufacturer of the anti-depressant drug Cymbalta, alleging not that they — October 23, 2015","breadcrumb":{"@id":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.molllawgroup.com\/blog\/california-judge-denies-class-certification-in-action-alleging-unfair-prices-for-prescription-meds\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.molllawgroup.com\/blog\/"},{"@type":"ListItem","position":2,"name":"California Judge Denies Class Certification In Action Alleging Unfair Prices for Prescription Meds"}]},{"@type":"WebSite","@id":"https:\/\/www.molllawgroup.com\/blog\/#website","url":"https:\/\/www.molllawgroup.com\/blog\/","name":"Illinois Injury and Mass Tort Lawyer Blog","description":"Published by Illinois Injury and Mass Tort Attorney \u2014 Moll Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.molllawgroup.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.molllawgroup.com\/blog\/#\/schema\/person\/53d2eb37d5d0cdb46ac61abacf05ce90","name":"Moll Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0febdc96ea554e620e775358f9d7e4fc56616188dfd2bb21b18c2fed4bd185a0?s=96&d=mm&r=g","caption":"Moll Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/92","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/comments?post=92"}],"version-history":[{"count":4,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/92\/revisions"}],"predecessor-version":[{"id":2333,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/posts\/92\/revisions\/2333"}],"wp:attachment":[{"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/media?parent=92"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/categories?post=92"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.molllawgroup.com\/blog\/wp-json\/wp\/v2\/tags?post=92"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}